Invention Grant
US08575199B2 Formula (IA″) compounds comprising (piperidin-4-yl)pyridine or (1,2,3,6-tetrahydropyridin-4-4yl) as TRPV1 antagonists 有权
包含(哌啶-4-基)吡啶或(1,2,3,6-四氢吡啶-4- 4-基)作为TRPV1拮抗剂的式(IA“)化合物

  • Patent Title: Formula (IA″) compounds comprising (piperidin-4-yl)pyridine or (1,2,3,6-tetrahydropyridin-4-4yl) as TRPV1 antagonists
  • Patent Title (中): 包含(哌啶-4-基)吡啶或(1,2,3,6-四氢吡啶-4- 4-基)作为TRPV1拮抗剂的式(IA“)化合物
  • Application No.: US13396450
    Application Date: 2012-02-14
  • Publication No.: US08575199B2
    Publication Date: 2013-11-05
  • Inventor: Laykea Tafesse
  • Applicant: Laykea Tafesse
  • Applicant Address: US CT Stamford
  • Assignee: Purdue Pharma L.P.
  • Current Assignee: Purdue Pharma L.P.
  • Current Assignee Address: US CT Stamford
  • Agency: Dechert LLP
  • Main IPC: A61K31/44
  • IPC: A61K31/44
Formula (IA″) compounds comprising (piperidin-4-yl)pyridine or (1,2,3,6-tetrahydropyridin-4-4yl) as TRPV1 antagonists
Abstract:
The invention relates to compounds of formula IA″ and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula IA″ or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula IA″ or a pharmaceutically acceptable derivative thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0